Summary
The computed 12-month bankruptcy probability of HemAdvice is 1.9% (moderate). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
No accounts; a small general or limited partnership need not file
Financial health
- Bankruptcy probabilitywithin 12 months
- 1.9%
No score: no figures
Structure
- Astrid HemeryckDirector
Signalsraises riskFounded in 2025Sector: Retail trade (NACE 47)lowers riskLegal form: limited partnershipNo annual accounts with figuresShow the evidence
Bankruptcy probability
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
04-2026: 1.2%lowest value
05-2026: 1.2%● unchanged vs 04-2026lowest value
06-2026: 1.2%● unchanged vs 05-2026
07-2026: 1.4%▲ +0.2 percentage points vs 06-2026
08-2026: 1.5%▲ +0.1 percentage points vs 07-2026
09-2026: 1.7%▲ +0.2 percentage points vs 08-2026
10-2026: 1.9%▲ +0.2 percentage points vs 09-2026highest value
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Four signals.
lowers riskraises risk
Searched, nothing found (1)
- IncorporationAppointment: Astrid Hemeryck (bestuurder,statutaire bestuurder)…
Financials
No annual accounts filed
No annual accounts of this company are filed with the National Bank. A small limited partnership whose unlimited partners are natural persons is not required to file.
Similar companies · same sector and region
APOTHEEK MAESSCHALCK-D'HAESE
BE 0691.667.606
Dilbeek
APOTHEEK PEDE
BE 0827.411.879
Dilbeek
BALSAM PHARMA CONSULTING
BE 1041.788.512
Dilbeek
DE MAEYER
BE 0451.496.891
Dilbeek
Elpers Farma
BE 0538.703.158
Dilbeek
No filed accounts are known for this company, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,202 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,874. See the whole sector
Subsidies and aid
Flemish government
2025 · 1 entry · €6,150 awarded · €6,150 paidPublic contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
1 director, no change since 2025
Astrid Hemeryck
CurrentBestuurder,statutaire bestuurder · since 10-03-2025
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2025, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Astrid Hemeryck |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
At incorporation
act of 24-03-2025 ↗
- Astrid Hemeryck beherende vennoot · 135 shares (40.3%) · €13,500
- Anne D’Haese stille vennoot · 100 shares (29.9%) · €10,000
- Stefan Hemeryck stille vennoot · 100 shares (29.9%) · €10,000
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 24-03-2025 Incorporation · €33,500 · 335 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
History
Acts, filings and financial milestones
2025
24-03
Gazette deed
IncorporationAppointment: Astrid Hemeryck (bestuurder,statutaire bestuurder) · Founder · Founding capital11 facts ▸
Gazette deed
Incorporation
Appointment: Astrid Hemeryck (bestuurder,statutaire bestuurder) · Founder · Founding capital11 facts ▸
- Incorporation, 10-03-2025
- Founder, Astrid Hemeryck (general partner)
- Founder, Anne D’Haese (limited partner)
- Founder, Stefan Hemeryck (limited partner)
- Founding capital, €33,500
- Partner, Astrid Hemeryck (general partner)
- Partner, Anne D’Haese (limited partner)
- Partner, Stefan Hemeryck (limited partner)
- Director appointment, Astrid Hemeryck (bestuurder,statutaire bestuurder)
- Director in office, Astrid Hemeryck (manager)
- Other provision, “Kruispuntbank gegevens, onbeperkt” (deed in Dutch)
Gazette deed
1 of 1 deed read
Register details
Identification
Legal formLimited partnership
Founded20-03-2025
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
63920Other information service activities
82100Office administrative and support services
82990Other business support services
86999Other human health activities
E-invoicing
Not found in the Peppol Directory
No listing in the Peppol Directory under this enterprise or VAT number. That proves nothing: being listed there is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance
If you follow this company, Checked tells you the day it appears in the Peppol register.
Register as of 23 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2025
Ground area
1,862 m²
Building footprint
166 m²
Building volume
1,006 m³
Parcel 23074A0019/00K000, Flanders · tallest building 8.3 m. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Molenstraat 120, 1700 Dilbeek
since 2025unit no. 2.372.063.041
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23074A0019/00K000 | Flanders | 1,862 m² | 1 · 166 m² | 8.2 m · 2 |
How the parcels are linked
Good to know
The parcel matches the address exactly.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Advies en bijstand aan apothekers; Onderzoek en ontwikkeling in de pharma,biotechnologie,biochemie en chemie; Contract research; Advies en…” (deed in Dutch)
7 activities (deed in Dutch)
- Advies en bijstand aan apothekers
- Onderzoek en ontwikkeling in de pharma,biotechnologie,biochemie en chemie
- Contract research
- Advies en bijstand aan de bedrijfswereld
- Secretariaatswerken
- Agentuur voor werving en aanstellen van consultants
- Overige adviesbureaus bedrijfsvoering
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- HemAdvice
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Molenstraat 120,1700 Dilbeek, overbrenging met meerderheid van 75% van de aandelen” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “De machten van de stille vennoot bestaan in: - de controle van de vennootschap, - de goedkeuring omtrent de vervreemding der financiële…”
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Overdracht onder levenden aan medevennoot of derde, toestemming van 75% van de aandeelhouders” (deed in Dutch)“Aandelen komen toe aan erfgenamen indien alle andere vennoten akkoord betuigen, geen binnenkomen zonder goedkeuring van de bestuurder” (deed in Dutch)
Meetings and financial year
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 January to 31 December
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 3 April
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bij geen benoeming wordt bestuurder in functie op tijdstip ontbinding van rechtswege vereffenaar met bevoegdheden vennootschappenwet,tenzij…” (deed in Dutch)